Abstract
Background: The Faroe Islands, Iceland, and Denmark are neighbouring Nordic countries with great ethnic, cultural, and
political similarities and are relatively homogeneous. Important information about prescribing practices can be obtained
by comparing the antibacterial use in these countries. The objective was to describe, compare, and analyse the use of systemic antibacterial agents in these countries during the y 1999 – 2011. Methods: Data were obtained from the Faroe Islands,
Iceland, and Denmark on systemic antibacterial use and expressed in defi ned daily dosages (DDD). Prescription data were
also obtained for specifi c age groups. Results: The total antibacterial use for the y 1999 – 2011 varied markedly between the
3 countries, with a mean use of 21.8 DDD/1000 inhabitants/day (DID) in Iceland, 17.7 in the Faroe Islands, and 16.3 in
Denmark. The total use remained fairly constant over the years in the Faroe Islands and Iceland, whereas in Denmark it
increased gradually from 13.5 DID in 1999 to 19.5 DID in 2011. The higher use in Iceland can be explained by much
higher consumption of tetracyclines. There was also considerable variation in the use of individual penicillins and macrolides
between the countries. Conclusions: Despite the great ethnic and cultural similarities of these 3 countries, we found marked
differences in total antibacterial use and important differences in the use of individual antibacterials.
political similarities and are relatively homogeneous. Important information about prescribing practices can be obtained
by comparing the antibacterial use in these countries. The objective was to describe, compare, and analyse the use of systemic antibacterial agents in these countries during the y 1999 – 2011. Methods: Data were obtained from the Faroe Islands,
Iceland, and Denmark on systemic antibacterial use and expressed in defi ned daily dosages (DDD). Prescription data were
also obtained for specifi c age groups. Results: The total antibacterial use for the y 1999 – 2011 varied markedly between the
3 countries, with a mean use of 21.8 DDD/1000 inhabitants/day (DID) in Iceland, 17.7 in the Faroe Islands, and 16.3 in
Denmark. The total use remained fairly constant over the years in the Faroe Islands and Iceland, whereas in Denmark it
increased gradually from 13.5 DID in 1999 to 19.5 DID in 2011. The higher use in Iceland can be explained by much
higher consumption of tetracyclines. There was also considerable variation in the use of individual penicillins and macrolides
between the countries. Conclusions: Despite the great ethnic and cultural similarities of these 3 countries, we found marked
differences in total antibacterial use and important differences in the use of individual antibacterials.
Original language | English |
---|---|
Pages (from-to) | 502-507 |
Number of pages | 7 |
Journal | Infectious Diseases |
Volume | 46 |
Issue number | 7 |
Publication status | Published - 2014 |
Externally published | Yes |
Keywords
- Antibacterial use
- Faroe Islands
- Iceland
- Denmark